FDA-Led Consortium Details Improvements Needed in Liquid Biopsies
The Scientist Magazine,
S everal liquid biopsy products have the ability to detect tumor DNA circulating in a patient’s blood, according to an analysis…
S everal liquid biopsy products have the ability to detect tumor DNA circulating in a patient’s blood, according to an analysis…
Although the field of circulating tumor DNA for DLBCL is young and clinical validation is needed, this technology is sure to…
Researchers at the Stanford University School of Medicine have devised a way to significantly increase the sensitivity of a…
Researchers at the Stanford University School of Medicine have devised a way to significantly increase the sensitivity of a…
Researchers at the Stanford University School of Medicine have devised a way to significantly increase the sensitivity of a…
Researchers at the Stanford University School of Medicine have devised a way to significantly increase the sensitivity of a…
循环肿瘤DNA(ctDNA)的高通量测序有望实现个性化的癌症治疗。不过,血液中的游离DNA(cfDNA)有限,限制了分析灵敏度。为此,斯坦福大学的研究人员近日开发出一种错误校正方法,能够检测到频率低至0.004%的突变等位基因。 在周一发表的《Nature…
NEW YORK (GenomeWeb) – A group of researchers from Stanford University has developed an error correction method for a…
Researchers at the Stanford University School of Medicine have devised a way to significantly increase the sensitivity of a…
Researchers at the Stanford University School of Medicine have devised a way to significantly increase the sensitivity of a…